Skip to Main Content

Paper Details

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses.
Immunity
28
2021
-, 555, 555 clonal lineages, B cell, Cav1, DS-Cav1-induced lineages, F, RSV, RSV F, antibody lineages, antigenic sites, fusion (F) glycoprotein, participants, pre, pre-, pre-F, pre-F trimer, predominant clonotype, prefusion conformation, public clonotypes, respiratory syncytial virus, respiratory syncytial virus fusion protein
Author NameAffiliation
Chen-Hsiang ShenVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Lingshu WangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Guillaume B E Stewart-JonesVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Nicole A Doria-RoseVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Jason S McLellanThe University of Texas at Austin
John R MascolaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • 1 - 7

Datasets

Release 1.2